background
nebulis
medic
aerosol
design
deliv
drug
lung
aid
treatment
respiratori
diseas
howev
unintend
consequ
potenti
fugit
emiss
patient
treatment
may
pose
risk
factor
clinic
homecar
set
method
current
studi
examin
potenti
fugit
emiss
use
albuterol
sulphat
tracer
aerosol
highflow
therapi
nasal
cannula
connect
head
model
altern
interfac
connect
tracheostomi
tube
combin
simul
adult
paediatr
breath
profil
two
aerodynam
particl
sizer
ap
record
timeseri
aerosol
concentr
size
distribut
two
differ
distanc
rel
simul
patient
result
result
show
quantiti
characterist
fugit
emiss
influenc
interfac
type
patient
type
supplement
gasflow
rate
trend
adult
scenario
flow
rate
increas
fugit
emiss
mass
median
aerodynam
diamet
mmad
aerosol
decreas
fugit
emiss
compar
use
adult
breath
profil
nasal
cannula
tracheostomi
interfac
howev
notic
distinct
two
interfac
compar
paediatr
breath
profil
highest
record
aerosol
concentr
mg
tracheostomi
interfac
simul
paediatr
breath
gasflow
rate
lmin
averag
mmad
across
combin
rang
ap
distanc
away
patient
interfac
conclus
overal
result
highlight
potenti
secondari
inhal
fugit
emiss
releas
simul
aerosol
treatment
concurr
highflow
therapi
find
help
develop
polici
best
practic
risk
mitig
fugit
emiss
aerosol
therapi
recognis
effect
method
administr
pharmaceut
procedur
involv
gener
aerosol
drug
deliveri
lung
aid
treatment
respiratori
diseas
nebulis
medic
aerosol
typic
particl
size
distribut
aerosol
particl
escap
indoor
environ
may
remain
airborn
period
sever
hour
aerosol
gener
technolog
deliv
drug
lung
neonat
paediatr
adult
patient
varieti
patient
interfac
sever
factor
influenc
aerosol
drug
deliveri
lung
includ
aerosolgener
devic
size
distribut
inhal
aerosol
gasflow
rate
inhal
pattern
type
interfac
dysart
et
al
report
use
highflow
nasal
therapi
hfnt
devic
rapidli
grow
clinic
set
differ
age
group
rang
diseas
condit
highflow
nasal
therapi
studi
report
gasflow
rate
lmin
paediatr
lmin
adult
studi
report
sever
factor
influenc
quantiti
aerosol
avail
inhal
includ
rate
ga
flow
deliv
size
nasal
prong
humidif
size
aerosol
droplet
aerosol
gener
type
posit
like
factor
also
influenc
quantiti
aerosol
avail
releas
fugit
emiss
fugit
emiss
consist
aerosol
exhal
patient
andor
aerosol
escap
system
prior
inhal
caregiv
famili
member
suscept
unintend
inhal
medic
occup
set
studi
highlight
concern
regard
secondari
exposur
aerosolis
sustain
releas
lipid
inhal
target
slit
cisplatin
pentamidin
adenoassoci
serotyp
vector
contain
cystic
fibrosi
transmembran
conduct
regul
complementari
dna
tgaavcf
ribavirin
addit
enter
profess
respiratori
therapist
report
increas
risk
develop
asthma
part
may
due
exposur
rang
aerosolis
substanc
clinic
set
date
limit
number
studi
examin
potenti
fugit
releas
aerosol
therapi
use
photograph
imag
somogyi
et
al
captur
releas
salin
aerosol
origin
patient
lung
even
patient
wear
facemask
addit
highdefinit
video
use
estim
dispers
distanc
smoke
particl
mimick
exhal
aerosol
releas
noninvas
ventil
mask
ventil
ari
et
al
examin
mechan
ventil
patient
without
expiratori
filter
case
without
use
filter
increas
deposit
drug
observ
exhaust
port
estim
greater
nomin
dose
could
fugit
releas
saeed
et
al
examin
exhal
filter
use
jet
vibrat
mesh
nebulis
vmn
found
gener
aerosol
releas
system
fugit
aerosol
surround
environ
elmasha
et
al
measur
aerosol
concentr
releas
adult
facemask
breath
zone
manikin
simul
homeattend
healthcar
worker
three
differ
distanc
total
aerosol
mass
concentr
rang
mgm
depend
distanc
manikin
rel
aerosol
sourc
although
medic
type
deem
influenc
factor
mcgrath
et
al
quantifi
timeseri
aerosol
concentr
size
distribut
fugit
aerosol
emiss
facemask
mouthpiec
interfac
releas
indoor
environ
timeweightedaverag
aerosol
concentr
record
mg
use
jet
nebulis
openfacemask
combin
effect
simul
aerosol
treatment
highflow
therapi
fugit
emiss
unclear
literatur
studi
examin
fugit
emiss
aerosol
drug
deliveri
combin
highflow
therapi
fugit
emiss
potenti
sourc
secondari
inhal
exposur
medic
aerosol
may
occur
clinic
set
number
key
factor
examin
could
influenc
secondari
exposur
includ
supplement
gasflow
rate
patient
type
distanc
interfac
optiflow
system
airvo
fisher
paykel
healthcar
auckland
new
zealand
use
adult
breath
circuit
pn
use
adult
nasal
cannula
pn
opt
tracheostomi
interfac
pn
opt
tracheostomi
tube
shiley
inner
cannula
tracheostomi
tube
id
medtron
galway
ireland
paediatr
breath
circuit
pn
use
paediatr
nasal
cannula
pn
opt
tracheostomi
interfac
pn
opt
tracheostomi
tube
shiley
paediatr
tracheostomi
tube
id
medtron
galway
ireland
airvo
hfnt
system
featur
humidifi
integr
flow
sourc
use
nebulis
adapt
nebulis
adapt
posit
humidif
chamber
test
complet
clinic
relev
gasflow
rate
lmin
lmin
lmin
simul
adult
hfnt
lmin
lmin
lmin
simul
paediatr
hfnt
tracheostomi
interfac
oper
lmin
clinic
set
result
run
perform
set
nasal
cannula
posit
nose
anatom
relev
nosethroat
model
accord
manufactur
instruct
nosethroat
model
connect
breath
simul
harvard
apparatu
dual
phase
control
respir
harvard
apparatu
usa
via
collect
filter
respirgard
ii
baxter
dublin
ireland
healthi
adult
breath
pattern
tidal
volum
ml
breath
rate
bpm
inspiratori
expiratori
ratio
healthi
paediatr
breath
pattern
tidal
volum
ml
breath
rate
bpm
inspiratori
expiratori
ratio
use
inhal
dose
determin
quantifi
mass
drug
filter
posit
distal
trachea
tracheostomi
interfac
tracheostomi
tube
attach
directli
collect
filter
addit
figur
contain
photograph
three
differ
combin
test
rig
suppli
supplementari
materi
figur
humidifi
power
allow
come
temperatur
degre
celsiu
ml
dose
albuterol
sulphat
mgml
glaxosmithklin
ltd
dublin
ireland
nebulis
experi
perform
use
aerogen
solo
vibrat
mesh
nebulis
aerogen
ltd
galway
ireland
albuterol
use
commonli
nebulis
drug
utilis
characteris
aerosol
drug
deliveri
system
end
dose
administr
drug
captur
filter
elut
use
ml
deionis
water
mass
drug
quantifi
mean
uv
spectrophotometri
wavelength
nm
interpol
standard
curv
albuterol
sulphat
concentr
result
inhal
dose
express
percentag
nomin
dose
place
nebulis
medic
cup
previous
describ
airway
model
adult
nosethroat
region
use
adult
model
model
small
child
nosethroat
region
nasal
caviti
pharynx
larynx
volum
cm
base
scan
femal
use
paediatr
model
aerodynam
particl
sizer
ap
ap
model
tsi
inc
st
paul
mn
usa
primari
aerosol
monitor
instrument
use
studi
throughout
experi
apss
continu
measur
aerosol
mass
concentr
size
distribut
airborn
concentr
room
apss
locat
distanc
away
patient
interfac
figur
two
distanc
chosen
basi
distanc
approxim
one
arm
length
away
simul
caregiv
hold
nebuliserfacemask
patient
face
distanc
select
approxim
repres
distanc
bed
primari
care
centr
simul
patient
situat
bed
next
patient
receiv
aerosol
therapi
laboratori
room
studi
conduct
dimens
l
w
h
air
chang
rate
measur
use
tracer
ga
decay
method
tracer
graywolf
probe
graywolf
sens
solut
shelton
ct
usa
use
ga
detect
air
chang
rate
calcul
approxim
h
room
temperatur
rel
humid
laboratori
room
measur
use
digit
hygrothermometerdatalogg
model
pacer
instrument
chippewa
fall
wi
usa
valu
record
rang
respect
experi
took
place
threeweek
period
data
analysi
studi
perform
use
statist
packag
ibm
spss
statist
ibm
corp
armonk
ny
usa
summari
descript
statist
perform
aerosol
concentr
distribut
characterist
summaris
arithmet
mean
standard
deviat
overal
trend
shown
tabl
indic
nasal
cannula
tracheostomi
interfac
flow
rate
increas
correspond
decreas
inhal
dose
adult
scenario
compar
flowrat
condit
similar
inhal
dose
found
nasal
cannula
tracheostomi
interfac
howev
stark
contrast
paediatr
scenario
compar
paediatr
nasal
cannula
deliv
tracheostomi
dose
flowrat
condit
paediatr
nasal
cannula
scenario
lower
inhal
dose
adult
scenario
paediatr
tracheostomi
scenario
higher
inhal
dose
adult
scenario
compar
inhal
dose
tracheostomi
interfac
nasal
cannula
paediatr
adult
patient
flowrat
condit
lmin
notic
differ
inhal
dose
indic
addit
factor
influenc
drug
deliveri
tabl
inhal
dose
record
nebulis
event
use
simul
adult
paediatr
breath
profil
nasal
cannula
tracheostomi
interfac
mean
standard
deviat
three
event
apss
set
record
data
interv
total
min
initi
fiveminut
period
establish
baselin
measur
ambient
aerosol
room
prior
activ
nebulis
remain
min
select
monitor
fugit
emiss
nebulis
period
consequ
aerosol
decay
nebulis
event
laboratori
vent
aerosol
concentr
monitor
return
ambient
level
laboratori
room
studi
conduct
dimens
l
w
h
air
chang
rate
measur
use
tracer
ga
decay
method
tracer
graywolf
probe
graywolf
sens
solut
shelton
ct
usa
use
ga
detect
air
chang
rate
calcul
approxim
h
room
temperatur
rel
humid
laboratori
room
measur
use
digit
hygrothermometerdatalogg
model
pacer
instrument
chippewa
fall
wi
usa
valu
record
rang
c
respect
experi
took
place
threeweek
period
data
analysi
studi
perform
use
statist
packag
ibm
spss
statist
ibm
corp
armonk
ny
usa
summari
descript
statist
perform
aerosol
concentr
distribut
characterist
summaris
arithmet
mean
standard
deviat
overal
trend
shown
tabl
indic
nasal
cannula
tracheostomi
interfac
flow
rate
increas
correspond
decreas
inhal
dose
adult
scenario
compar
flowrat
condit
similar
inhal
dose
found
nasal
cannula
tracheostomi
interfac
howev
stark
contrast
paediatr
scenario
compar
paediatr
nasal
cannula
deliv
tracheostomi
dose
flowrat
condit
paediatr
nasal
cannula
scenario
lower
inhal
dose
adult
scenario
paediatr
tracheostomi
scenario
higher
inhal
dose
adult
scenario
compar
inhal
dose
tracheostomi
interfac
nasal
cannula
paediatr
adult
patient
flowrat
condit
lmin
notic
differ
inhal
dose
indic
addit
factor
influenc
drug
deliveri
figur
repres
averag
three
run
per
scenario
demonstr
initi
fiveminut
baselin
ambient
concentr
increas
aerosol
concentr
nebulis
period
consequ
decay
follow
nebulis
increas
aerosol
concentr
attribut
fugit
emiss
highflow
therapi
interfac
tabl
summaris
peak
aerosol
concentr
record
distanc
patient
interfac
across
scenario
ratio
averag
peak
measur
respect
distanc
rang
shown
figur
main
differ
aros
period
five
fifteen
minut
commenc
nebulis
period
proxim
interfac
result
higher
concentr
howev
nebulis
ceas
concentr
two
distanc
converg
compar
remain
min
peak
concentr
reach
min
distanc
away
patient
interfac
min
distanc
howev
major
peak
concentr
occur
min
correspond
durat
nebulis
period
highlight
cumul
fugit
emiss
highflow
therapi
interfac
mean
standard
deviat
averag
fiveminut
baselin
ambient
aerosol
concentr
mg
tabl
summaris
timeweight
averag
nasal
cannula
tracheostomi
scenario
adult
paediatr
patient
distanc
scenario
airflow
rate
lmin
higher
aerosol
concentr
record
distanc
patient
interfac
howev
airflow
rate
lmin
higher
concentr
record
distanc
due
mean
standard
deviat
averag
fiveminut
baselin
ambient
aerosol
concentr
mg
tabl
summaris
timeweight
averag
nasal
cannula
tracheostomi
scenario
adult
paediatr
patient
distanc
scenario
airflow
rate
lmin
higher
aerosol
concentr
record
distanc
patient
interfac
howev
airflow
rate
lmin
higher
concentr
record
distanc
due
mean
standard
deviat
averag
fiveminut
baselin
ambient
aerosol
concentr
mg
tabl
summaris
timeweight
averag
nasal
cannula
tracheostomi
scenario
adult
paediatr
patient
distanc
scenario
airflow
rate
lmin
higher
aerosol
concentr
record
distanc
patient
interfac
howev
airflow
rate
lmin
higher
concentr
record
distanc
due
increas
dispers
aerosol
throughout
room
nasal
cannula
tracheostomi
simul
adult
breath
decreas
aerosol
concentr
increas
gasflow
rate
interfac
yield
compar
aerosol
concentr
lmin
greater
decreas
concentr
nasal
cannula
comparison
tracheostomi
higher
flow
rate
lmin
tracheostomi
aerosol
concentr
twice
nasal
cannula
concentr
differ
trend
observ
nasal
cannula
tracheostomi
paediatr
breath
highest
aerosol
concentr
observ
lowest
gasflow
rate
nasal
cannula
highest
concentr
observ
highest
gasflow
rate
tracheostomi
interfac
notic
differ
aerosol
concentr
measur
nasal
cannula
tracheostomi
interfac
simul
paediatr
breath
howev
variat
occur
nasal
cannula
tracheostomi
interfac
adult
patient
adult
paediatr
patient
tracheostomi
interfac
tabl
summaris
averag
mass
median
aerodynam
diamet
mmad
period
term
mass
concentr
record
ap
distanc
away
patient
interfac
tabl
summari
averag
mass
median
aerodynam
diamet
nebulis
event
use
two
interfac
nasal
cannula
tracheostomi
three
gasflow
rate
simul
adult
paediatr
patient
mean
standard
deviat
three
event
averag
mmad
consid
combin
tabl
mmad
paediatr
breath
pattern
nasal
cannula
interfac
reflect
ambient
aerosol
concentr
fugit
emiss
releas
nebulis
system
remain
combin
mmad
distanc
mmad
compar
tracheostomi
interfac
nasal
cannula
lmin
regardless
patient
interfac
gasflow
rate
overal
gasflow
rate
increas
mmad
across
patient
interfac
decreas
work
exampl
two
differ
type
patient
interfac
highflow
therapi
examin
aerosol
deliveri
estim
potenti
inhal
exposur
first
caregiv
assum
distanc
patient
bystand
assum
distanc
inhal
exposur
calcul
adult
nasal
cannula
scenario
paediatr
tracheostomi
lmin
use
timeseri
averag
data
scenario
focu
sole
fugit
emiss
interfac
fiveminut
baselin
averag
aerosol
concentr
subtract
timeseri
data
shortterm
exposur
inhal
rate
min
min
select
repres
caregiv
bystand
respect
caregiv
assum
light
intens
activ
level
bystand
assum
sedentarypass
activ
level
scenario
caregiv
bystand
estim
potenti
expos
origin
drug
respect
nasal
cannula
interfac
correspond
valu
tracheostomi
interfac
respect
studi
examin
potenti
secondari
inhal
medic
aerosol
emit
highflow
therapi
fugit
emiss
examin
nasal
cannula
tracheostomi
interfac
three
differ
gasflow
rate
simul
paediatr
adult
breath
patient
breath
simul
head
model
nasal
cannula
tracheostomi
interfac
tracheostomi
tube
use
simul
healthi
adult
paediatr
breath
releas
environ
ap
characteris
timeseri
aerosol
concentr
size
distribut
reflect
fugit
emiss
highflow
interfac
select
current
methodolog
isol
fugit
emiss
ambient
aerosol
chang
timeseri
concentr
highlight
ambient
aerosol
minor
contributor
shown
figur
increas
aerosol
concentr
attribut
releas
fugit
aerosol
surround
current
approach
differenti
aerosol
releas
prior
inhal
aerosol
possibl
exhal
inhal
use
collect
filter
wide
use
suitabl
method
determin
inhal
dose
might
truli
repres
simul
real
exhal
howev
sinc
overal
percentag
inhal
dose
rel
small
assum
major
fugit
emiss
consist
aerosol
escap
prior
inhal
vibrat
mesh
nebulis
technolog
gener
aerosol
contract
expans
vibrat
element
produc
movement
apertur
plate
produc
aerosol
approach
requir
compress
air
gener
aerosol
size
aerosol
flow
determin
exit
diamet
apertur
hole
previou
research
show
residu
mass
remain
vmn
independ
patient
interfac
heat
humidif
set
vmn
use
scenario
aerosol
gener
rate
consist
across
scenario
chang
inhal
dose
fugit
emiss
influenc
patient
interfac
gasflow
rate
breath
profil
result
indic
inhal
dose
decreas
increas
gasflow
rate
except
nasal
cannula
paediatr
breath
profil
lmin
lower
inhal
dose
lmin
although
clear
explan
result
one
potenti
reason
may
lmin
aerosol
forc
system
includ
perhap
drug
rain
head
model
remain
trend
consist
studi
perri
et
al
examin
inhal
dose
highflow
nasal
cannula
therapi
use
aerogen
solo
devic
simul
adult
breath
inhal
dose
found
gasflow
rate
lmin
respect
howev
studi
found
lmin
respect
simul
paediatr
breath
found
gasflow
rate
lmin
compar
studi
find
flow
rate
lmin
dailey
et
al
examin
inhal
dose
use
highflow
nasal
cannula
report
consider
higher
valu
lmin
lmin
lmin
perri
et
al
use
lower
tidal
volum
paediatr
breath
profil
set
present
studi
dailey
et
al
use
inspiratoryexpiratori
ratio
albuterol
sulphat
mixtur
ml
neither
studi
report
length
tube
intern
diamet
nasal
prong
make
direct
comparison
difficult
differ
studi
flow
rate
overal
trend
remain
similar
direct
comparison
inhal
dose
difficult
due
sever
factor
influenc
drug
avail
inhal
posit
compon
ventil
circuit
simul
breath
set
humidif
affect
inhal
dose
golshahi
et
al
report
increas
tube
length
cm
cm
increas
deposit
fraction
tube
compar
tube
length
use
current
studi
higher
inhal
dose
higher
fugit
emiss
indic
major
loss
mechan
occur
prior
exit
patient
interfac
dailey
et
al
report
increas
flow
rate
could
increas
turbul
impact
loss
aerosol
within
tube
mean
less
aerosol
reach
patient
interfac
avail
inhal
andor
releas
fugit
aerosol
studi
vibrat
mesh
nebulis
use
gener
medic
aerosol
previou
work
report
aerosol
gener
vmn
mmad
howev
observ
averag
mmad
fugit
emiss
rang
across
scenario
aerosol
releas
environ
consider
smaller
origin
gener
nebulis
larger
size
aerosol
combin
air
flow
experi
greater
inertia
increas
rate
impact
deposit
larger
size
aerosol
within
system
upon
head
model
consequ
fugit
emit
aerosol
domin
lower
size
fraction
aerosol
decreas
mmad
bhashyam
et
al
report
volum
median
diamet
aerosol
nasal
cannula
aerosol
deliveri
system
use
lmin
drive
flow
aerosol
exit
nebulis
reduc
adult
cannula
paediatr
cannula
although
higher
gasflow
rate
use
current
studi
similar
trend
found
decreas
size
fraction
size
leav
patient
interfac
berlinski
report
aerosol
size
fraction
exit
tip
tracheostomi
tube
berlinski
report
aerosol
chang
characterist
travel
tracheostomi
tube
effect
notic
nebulis
aerosol
meter
dose
inhal
valv
aerosol
reservoir
addit
simul
adult
breath
gasflow
rate
lmin
compar
trend
nasal
cannula
tracheostomi
interfac
could
indic
size
distribut
fugit
emiss
independ
patient
interfac
govern
instead
flow
veloc
scenario
size
fraction
releas
aerosol
implic
aerosol
remain
airborn
longer
period
link
secondari
inhal
exposur
aerosol
concentr
govern
local
factor
includ
room
dimens
layout
air
turbul
airflow
rate
temperatur
influenc
dispers
decay
howev
previou
research
mcgrath
al
conduct
laboratori
allow
comparison
current
studi
fugit
emiss
standard
jet
nebulis
use
manufacturerprescrib
lmin
adult
paediatr
head
model
connect
patient
interfac
facemask
mouthpiec
without
expiratori
filter
exhal
port
adjust
reflect
analysi
present
studi
aerosol
concentr
rang
mg
compar
observ
concentr
rang
mg
current
studi
studi
indic
caregiv
expos
higher
fugit
emiss
bystand
due
proxim
patient
interfac
worth
note
calcul
exposur
ratio
bystand
versu
caregiv
caregiv
inhal
origin
drug
use
nasal
cannula
compar
tracheostomi
howev
bystand
inhal
nasal
cannula
scenario
compar
tracheostomi
scenario
due
occurr
peak
exposur
previous
document
indoor
air
qualiti
studi
contrast
aerosol
concentr
record
nasal
cannula
scenario
paediatr
adult
patient
reflect
tracheostomi
scenario
paediatr
nasal
cannula
smaller
tube
dimens
compon
could
affect
aerosol
exit
interfac
adult
nasal
cannula
opt
inner
diamet
nasal
prong
mm
narrowest
point
paediatr
nasal
cannula
opt
inner
diamet
nasal
prong
mm
narrowest
point
studi
report
characterist
paediatr
setup
reduc
aerosol
exit
cannula
highflow
therapi
sinc
tube
tracheostomi
interfac
mm
narrowest
point
use
adult
paediatr
tracheostomi
differ
breath
profil
could
explain
differ
observ
case
fugit
emiss
releas
aerosol
therapi
present
potenti
risk
healthcar
worker
clinic
set
date
limit
studi
exist
examin
fugit
emiss
releas
surround
studi
previous
quantifi
timeseri
aerosol
concentr
size
distribut
fugit
emiss
highflow
therapi
potenti
inhal
exposur
fugit
emiss
highflow
aerosol
therapi
examin
use
adult
paediatr
scenario
nasal
cannula
tracheostomi
interfac
studi
confirm
releas
fugit
emiss
environ
aerosol
highflow
treatment
result
show
variat
interfac
type
patient
adult
paediatr
gasflow
rate
impact
quantiti
characterist
fugit
emiss
highest
aerosol
concentr
mg
record
paediatr
tracheostomi
gasflow
rate
lmin
also
correspond
second
highest
inhal
dose
across
scenario
observ
gasflow
rate
increas
inhal
dose
decreas
fugit
emiss
decreas
overal
result
use
develop
approach
healthcar
provid
patient
inform
best
practic
mitig
risk
fugit
emiss
clinic
practic
supplementari
materi
follow
avail
onlin
http
figur
photograph
highlight
physic
setup
paediatr
nasal
cannula
set
figur
photograph
highlight
physic
setup
adult
nasal
cannula
set
figur
